114 related articles for article (PubMed ID: 34707096)
21. The molecular pathogenesis of craniopharyngiomas.
Campanini ML; Almeida JP; Martins CS; de Castro M
Arch Endocrinol Metab; 2023 Mar; 67(2):266-275. PubMed ID: 36748936
[TBL] [Abstract][Full Text] [Related]
22. In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas.
Kim JH; Kim H; Dan K; Kim SI; Park SH; Han D; Kim YH
Sci Rep; 2021 Oct; 11(1):21206. PubMed ID: 34707096
[TBL] [Abstract][Full Text] [Related]
23. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
[TBL] [Abstract][Full Text] [Related]
24. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
Esheba GE; Hassan AA
J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
[TBL] [Abstract][Full Text] [Related]
25. Exploration of the shared pathways and common biomarker in adamantinomatous craniopharyngioma and type 2 diabetes using integrated bioinformatics analysis.
Han Y; Wang Y; Li S; Sato K; Yamagishi S
PLoS One; 2024; 19(6):e0304404. PubMed ID: 38848397
[TBL] [Abstract][Full Text] [Related]
26. Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
Apps JR; Carreno G; Gonzalez-Meljem JM; Haston S; Guiho R; Cooper JE; Manshaei S; Jani N; Hölsken A; Pettorini B; Beynon RJ; Simpson DM; Fraser HC; Hong Y; Hallang S; Stone TJ; Virasami A; Donson AM; Jones D; Aquilina K; Spoudeas H; Joshi AR; Grundy R; Storer LCD; Korbonits M; Hilton DA; Tossell K; Thavaraj S; Ungless MA; Gil J; Buslei R; Hankinson T; Hargrave D; Goding C; Andoniadou CL; Brogan P; Jacques TS; Williams HJ; Martinez-Barbera JP
Acta Neuropathol; 2018 May; 135(5):757-777. PubMed ID: 29541918
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice.
Apps JR; Martinez-Barbera JP
Neurosurg Focus; 2016 Dec; 41(6):E4. PubMed ID: 27903120
[TBL] [Abstract][Full Text] [Related]
28. Adamantinomatous craniopharyngioma: advances in proteomic research.
Desiderio C; Rossetti DV; Castagnola M; Massimi L; Tamburrini G
Childs Nerv Syst; 2021 Mar; 37(3):789-797. PubMed ID: 32617710
[TBL] [Abstract][Full Text] [Related]
29. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
[TBL] [Abstract][Full Text] [Related]
30. Biological Behaviour of Craniopharyngiomas.
Martinez-Barbera JP; Andoniadou CL
Neuroendocrinology; 2020; 110(9-10):797-804. PubMed ID: 32126562
[TBL] [Abstract][Full Text] [Related]
31. Hypoxic environment may enhance migration/penetration of endocrine resistant MCF7- derived breast cancer cells through monolayers of other non-invasive cancer cells in vitro.
Barrak NH; Khajah MA; Luqmani YA
Sci Rep; 2020 Jan; 10(1):1127. PubMed ID: 31980706
[TBL] [Abstract][Full Text] [Related]
32. Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages.
Wu H; Han Y; Rodriguez Sillke Y; Deng H; Siddiqui S; Treese C; Schmidt F; Friedrich M; Keye J; Wan J; Qin Y; Kühl AA; Qin Z; Siegmund B; Glauben R
EMBO Mol Med; 2019 Nov; 11(11):e10698. PubMed ID: 31602788
[TBL] [Abstract][Full Text] [Related]
33. Recurrence Rate and Prognostic Factors for the Adult Craniopharyngiomas in Long-Term Follow-Up.
Park HJ; Dho YS; Kim JH; Kim JW; Park CK; Kim YH
World Neurosurg; 2020 Jan; 133():e211-e217. PubMed ID: 31493596
[TBL] [Abstract][Full Text] [Related]
34. ERRα as a Bridge Between Transcription and Function: Role in Liver Metabolism and Disease.
Xia H; Dufour CR; Giguère V
Front Endocrinol (Lausanne); 2019; 10():206. PubMed ID: 31024446
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Proteome Analysis of Brain Subregions and Spinal Cord from Experimental Autoimmune Encephalomyelitis Mice by TMT-Based Mass Spectrometry.
Hasan M; Min H; Rahaman KA; Muresan AR; Kim H; Han D; Kwon OS
Proteomics; 2019 Mar; 19(5):e1800355. PubMed ID: 30724464
[TBL] [Abstract][Full Text] [Related]
36. Craniopharyngioma: a roadmap for scientific translation.
Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
